BioWorld MedTech

Dec. 23, 2009

View Archived Issues

GI wins CE mark for EndoBarrier as treatment of diabetes, obesity

Patients in Europe now have a non-surgical treatment option for Type 2 diabetes and obesity – a device known as the EndoBarrier from GI Dynamics (Lexington, Massachusetts). (Medical Device Daily) Read More

New imaging agent may eliminate invasive breast cancer biopsies

Read More

Report from Europe: DePuy buys Finsbury Ortho for estimated €60 million

Read More

Washington roundup: Senate scrambling to pass a healthcare bill by Christmas

Read More

Deals roundup: Derma in licensing pact with Comvita for wound products

Read More

Today's MDD food for med-tech thought

Read More

Financings roundup: EnzySurge raises $2.5M round; IBM lends to EHR providers

Read More

Agreements/contracts: Nonin Medical expands alliance with CareFusion

Read More

Product Briefs

Read More

People in the News

Read More

MDD's Oncology Extra

Read More